Musings on the Pharmaceutical industry

Rick Venglarcik RickV at
Mon Jul 22 11:50:12 EDT 2002

-It reportedly costs $500 million to bring a pharmaceutical product to
market (other literature indicates this an exaggerated figure).

-Pharmaceutical companies are always looking to "knock it out of the
ballpark;" they are very satisfied with a pharmacotherapy that brings in
$1 million per day.

-Pharmacological treatment of addiction, and numerous other
statistically insignificant diseases, won't result in an "out of the
ballpark" product.

-MAINTENANCE drugs for the treatment (alleviation of symptoms) of
various diseases, are very profitable. 

The foregoing brings to mind this question:  
What possible motive would there be for any pharmaceutical company to
research and develop medications that would actually "cure"
insignificant diseases?  Or significant ones for that matter.  What if,
as a result of unraveling the human genome, pharmaceutical companies
could develop medications that would alleviate the need for any kind of
maintenance drugs, but, instead, would cure the disease in only a few
applications?   Would they be pursued?

Just wondering.

Rick Venglarcik, MA, CSAC
Hampton Roads Clinic
2236 W. Queen St., Suite C
Hampton,  VA  23666

Office:  (757) 827-8430 x144
Fax:  (757) 826-2772
Cell: (757) 270-9839

-------------- next part --------------
An embedded and charset-unspecified text was scrubbed...
Name: Rick Venglarcik.vcf
URL: <>

More information about the Ibogaine mailing list